Investment

A SAR 500M Saudi MedTech platform with multiple revenue engines

SI Vision MedTech offers a phased capital strategy from a SAR 45M operational start to a SAR 500M sovereign platform — with six diversified revenue streams and GCC export upside.

Initial Phase
SAR 45M

Advanced repair operations, refurbishment lab and AI pilot.

Strategic Phase
Phase 1–3
SAR 150M

GCC expansion, manufacturing localization and AI scale-up.

Full Platform Vision
SAR 500M

National platform: manufacturing, AI, training academy and therapeutic technologies.

Revenue Engines

Six diversified revenue streams

Repair & Maintenance Contracts
Refurbished Device Sales
Manufactured Components & Devices
AI Platform Licensing (SaaS)
Training Academy Revenue
R&D & IP Royalties

Invest in the next generation of Saudi healthcare technology

A strategic, Vision 2030–backed opportunity with GCC expansion potential and long-term value-based returns.